Résumé
Background: Price of a drug is an important factor for compliance to the treatment. So, to overcome the high prices of drugs, National Pharmaceutical Pricing Authority (NPPA) under government of India has issued Drug Price Control Order (DPCO) list containing commonly used drugs. Pharmaceutical companies can be punished if they keep their prices higher than the ceiling price mentioned in the DPCO. To find out the price variations of commonly used antidepressant drugs included in DPCO list of 29th April 2019.Methods: A list of all oral antidepressant drugs included in DPCO of 29th April 2019 and available in Indian market was procured from medguide India. Analysis of number of total brands following as well as not following DPCO ceiling price was done.Results: Author found 17 formulations of four antidepressant drugs included in DPCO. Total 556 brands found out of which 84.6% were following the DPCO and 15.4% of brands prices were higher than the ceiling price of DPCO.Conclusions: Though large number of companies are following the DPCO but still strict regulation is needed to further increase the compliance of guidelines.
Résumé
Background: The objective of the present study was to analyze the prices of metformin, losartan, atorvastatin, paracetamol and aspirin for the doses which are included in the list of Drug Price Control Order (DPCO) 2013.Methods: Current index medical specialties India, 37th year, April-July 2015 issue was used for analysis. The retail prices of the drugs in INR were tabulated in Microsoft Office Excel 2013. The prices of the above listed drugs were compared with prices of DPCO 2013 for the same doses of drugs. The analysis of drugs costing more than the prices listed in the DPCO with the margin of the difference in percentage was carried out.Results: Out of 25 brands of metformin 500 mg tablet, 11 (44%) brands had price higher than listed in DPCO 2013. Similarly, prices for losartan 25 mg and 50 mg tablets, 8 (25%) out of 32 and 11 (31.42%) out of 35 were higher respectively. For atorvastatin 5 mg and 10 mg tablets, 2 (9.52%) out of 21 and 8 (13.55%) out of 59 brands had higher prices. For paracetamol 500 mg tablet, 12 (63.15%) out of 19 brands were priced higher than DPCO list. For aspirin 100 mg tablet and 325 mg tablet, 3 (100%) out of 3 brands and 1 (100%) out of 1 brand had higher prices.Conclusions: Many of the brand formulations have higher prices than the DPCO 2013 issued by government of India. The clinicians prescribing these drugs should be aware of these brand formulations to reduce the cost of the drug therapy.
Résumé
Background: Acquired immunodeficiency syndrome (AIDS) is a disorder caused by the human immunodeficiency virus (HIV). Main characteristic feature of AIDS includes severe immunosuppression which leads to opportunistic infections which is a main cause of death and requires a lifelong therapy. There exists wide range of cost variation in antiretroviral drugs that are marketed in India. The current study aims to view the existing situation of antiretroviral drugs, by collecting data about the cost of common antiretroviral drugs available either singly or in combination and to evaluate the difference in cost of different brands of same active drug by calculating percentage cost variation.Methods: Data for calculating cost ratio and percentage price variation of various antiretroviral drugs was obtained from 揅urrent Index of Medical Specialties� October 2017-January2018.Results: Zidovudine 100mg shows maximum cost ratio and price variation followed by Lamivudin 100mg in the single drug therapy. Lamivudine 150mg + Zidovudine 300mg shows maximum price variation in combination drug therapy.Conclusions: Indian market shows wide price variation of different brands of the same generic antiretroviral drug. To decrease the wide cost variation among different brands of antiretroviral drugs; it is time to create awareness among healthcare professionals about impact of cost effectiveness of drug regimen and decrease the financial burden on the patients.
Résumé
Background: AIDS is one of the most prevalent causes of death due to infectious origin which requires a lifelong therapy. There is variation in prices of antiretroviral drugs available in Indian market. Thus, a study was planned to find out variation in prices of antiretroviral drugs either as a single drug or in combination and to evaluate the difference in cost of various brands of the same antiretroviral drugs by calculating percentage variation in cost in Indian rupees. Methods: Cost of antiretroviral drugs manufactured by different pharmaceutical companies, in the same strength and dosage forms was obtained from “Current Index of Medical Specialties” July-October 2014 and “Indian Drug Review” Vol. XXI, Issue No. 4, 2014. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical companies and percentage variation in cost was calculated. Results: Percentage variation in cost for antiretroviral drugs marketed in India was found to be zidovudine (100 mg) - 436%, lamivudine (100 mg) - 268%, tenofovir (300 mg) - 149.5%, didanosine (250 mg) - 73.75%, indinavir (400 mg) - 35.26%. Among the combination therapy, price variation was lamivudine + zidovudine (150 + 300 mg) - 314%, lamivudine + stavudine (150 + 40 mg) - 105%, lopinavir + ritonavir (133.3 + 33 mg) - 25%. Conclusion: There is wide variation in the prices of antiretroviral agents available in the market. Regulatory authorities, pharma companies, physicians should maximize their efforts to reduce the cost of drugs.
Résumé
Price control is common in the national health system in the worldwide, in which the price control to physician's labor in China’s health system is relatively unique phenomenon. This mean of using the most important procedure factors in price control of the whole system has caused a series of adverse consequences: the interference of signal function of price, medical institutions relying too much on drug sales, the doctor’s behavior alienation, and agency relationship between doctor and patient failed resulting in the high tension of doctor-patient relationship. China’s health system got sick, and the price control to physician’s labor is the most important source. Let the price of doctor’s labor decided by the market mechanism is an important chose to regain the healthy development for China’s health system.
Résumé
OBJECTIVE:To discuss the ways to improve the drug control outcome in China and to facilitate the related system reform.METHODS:The causes and countermeasures for the failure of drug control policy in China were analyzed comparatively using economic theory.RESULTS & CONCLUSIONS:Information dissymmetry in the medicine area,monopoly of medical institution and their evasion of control etc all resulted in the failure of price control policy.To avoid this failure,it is necessary to take reform measures in many aspects,enhance the scientificity of price control,and improve the conduction mechanism of price control policy.
Résumé
Establishing harmonious physician-patient relationship is importamt to set up the harmonious society.Some hospitals try in recent years a line the single disease grows the price control charges,which suggest its importamt role in seting up harmonious physician-patient relationship,and greatly attract public's concern as the new measure in this aspect.
Résumé
This text is from the angle that the medical treatment consume,growing the tallest price control for the single disease to consume to the medical treatment the influence that Chinese medicine get relation launch the study.This be: The single disease grows the tallest price control overcame the sufferer in medical treatment consume information bad situation this"market normal",real realizes the medical treatment consume public and transparent;Overcome medical treatment consume inside then cure square is predominant consume to sufferers inducements and"act for need",realizes to match the sufferer original meaning"ego need";Well now to the sufferer in medical treatment consume of knowing what happened and agreeing the respect between power and independence option;Is profession self-discipline consciousness that the medical ethics vogue that the medical treatment organization is active to promote trustworthiness as the occupation morals norm in medical treatment serve,set up to take the letter in the people,now medical treatment organization.